Phibro Animal Health Corporation · NASDAQ:PAHC
Phibro Animal Health — Q1 2021 Earnings Presentation
13 slides from Phibro Animal Health's earnings presentation, Nov 5, 2020
Slide 1: Phibro Animal Health Corporation
Phibro Animal Health Corporation First Quarter – September 30, 2020 U.S. toll-free +1-833-968-1955 Webcast and Conference Call International toll +1-647-689-6656 November 5, 2020 Conference ID: 8813439
Slide 2: Cautionary Statements
Cautionary Statements Forward-Looking Statements This communication contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical or current fact included in this report are forward-looking statements. Forward-looking statements d
Slide 3: GAAP and Non-GAAP Financial Information
GAAP and Non-GAAP Financial Information Reported results are presented in accordance with GAAP Adjusted results are GAAP results adjusted to exclude - Acquisition-related items, including intangible amortization, cost of goods sold and transaction costs - Unusual, non-operational or non-recurring it
Slide 4: Opening Remarks and Financial Review
Opening Remarks and Financial Review Jack Bendheim Chairman, President, Chief Executive Officer Richard Johnson Chief Financial Officer Damian Finio Incoming Chief Financial Officer 4 November 5, 2020 Webcast and Conference Call
Slide 5: Highlights
Highlights Q1 – September 2020 Consolidated Sales increase driven by the Animal Health segment, partially offset by lower Mineral Nutrition For the three months ended sales. Performance Product sales were 2020 2019 Change comparable to the prior year. Animal Health September 30 (in millions, except
Slide 6: Selected Line Items
Selected Line Items Q1 – September 2020 Consolidated Adjusted gross profit - Animal Health increased due to sales growth, 2020 Change For the three months ended September 30 2019 favorable product mix and favorable production (in millions, except per share amounts and percentages) costs, primarily d
Slide 7: Animal Health
Animal Health Q1 – September 2020 MFAs and other Animal Health For the three months ended - Increased international demand in poultry products 2020 2019 Change and timing of certain customer orders September 30 (in millions, except percentages) Nutritional specialties MFAs and other $ 78.7 $ 75.0 $
Slide 8: Other Segments
Other Segments Q1 – September 2020 For the three months ended September 30 2020 2019 Change Mineral Nutrition (in millions, except percentages) Mineral Nutrition - Volume growth was offset by lower average selling prices Net sales $ 51.4 $ 52.6 $ (1.2) (2)% - Adjusted EBITDA decrease driven primaril
Slide 9: Capitalization
Capitalization September 30, 2020 3.7x leverage ratio at September 30, 2020 - $399 million total debt - $107 million LTM Adjusted EBITDA $92 million cash and short-term investments on hand at September 30, 2020 $6 million use of cash before financing for the September 2020 quarter, excluding changes
Slide 10: Guidance
Guidance Q2 – December 2020 We continue to forecast only near-term expectations, given the uncertainty of the future course of the pandemic and the ongoing difficult conditions in the industry. The animal production industry continues to recover from the effects of the pandemic. We believe industry
Slide 11: Guidance
Guidance Q2 – December 2020 We are encouraged by the improving trends in our business. Compared to our financial results for the September 2020 quarter, our expected December 2020 quarterly net sales, adjusted EBITDA and adjusted diluted EPS are expected to increase by $10 million, $1.7 million and
Slide 12: Q&A Session
Q&A Session 12 November 5, 2020 Webcast and Conference Call
Slide 13: © 2020 Phibro Animal Health Corporation
© 2020 Phibro Animal Health Corporation, Teaneck, NJ 07666 Phibro; Phibro logo design; Healthy Animals. Healthy Food. Healthy World.; and any other Phibro brand or brands shown herein are trademarks owned by or licensed to Phibro Animal Health Corporation or its affiliates. Any other trademark that